ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
수의용 바이오마커 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 9억 1,000만 달러에서 2026년에는 10억 2,000만 달러로, CAGR 12.4%로 성장이 전망되고 있습니다. 과거 성장 요인으로는 기존 진단법에 대한 의존도, 바이오마커의 가용성 제한, 동물 질병의 확산, 기존 수의학 연구 방법, 전임상 연구 툴의 낮은 도입률 등을 들 수 있습니다.
수의 바이오마커 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 16억 1,000만 달러에 달하며, CAGR은 12.0%에 달할 전망입니다. 예측 기간 중의 성장은 바이오마커 발견 기술의 발전, 수의 진단에 대한 투자 증가, 동물 건강 모니터링에 대한 의식의 향상, 반려동물 및 생산 동물 부문의 성장, 자동화된 바이오마커 판독기 및 디지털 플랫폼의 도입에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 진단용 바이오마커 개발 확대, 예측 및 예후 바이오마커 응용 분야 성장, ELISA, PCR, 신속 검사 키트 채택 증가, 첨단 바이오마커 리더 및 분석기기의 사용 확대, 반려동물 및 생산 동물의 헬스케어에 대한 관심 증가 등을 들 수 있습니다. 등을 꼽을 수 있습니다.
향후 반려동물 양육률 증가가 수의학 바이오마커 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물 사육은 한 마리 이상의 동물을 반려동물로 키우고, 개인이 반려동물의 필요와 복지를 충족시키기 위해 돌봄, 주거, 관심을 제공하는 상태를 말합니다. 반려동물 양육 증가는 반려동물을 키우고자 하는 욕구, 반려동수처리의 이점, 반려동물이 정신적, 신체적 건강에 미치는 긍정적인 영향에 대한 인식 증가 등의 요인에 기인합니다. 수의학 바이오마커는 동물의 건강 상태를 모니터링하고, 질병을 조기에 발견하고, 맞춤형 치료 계획을 수립할 수 있도록 지원함으로써 반려동물 사육을 돕습니다. 예를 들어 반려동물 사료 및 간식 제조업체를 위한 미국의 주요 정보원인 Petfood Industry에 따르면 2025년 6월 기준 미국의 9,400만 가구가 최소 1마리 이상의 반려동물을 키우고 있으며, 이는 2023년 8,200만 가구에서 증가한 수치입니다. 이는 반려동물을 키우는 인구가 크게 증가하고 애완동물 케어 제품 및 서비스에 대한 수요가 확대되고 있음을 반영합니다. 따라서 반려동물 사육 수 증가가 수의학 바이오마커 시장의 성장을 촉진하고 있습니다.
수의학 바이오마커 시장의 주요 기업은 경쟁 우위를 강화하기 위해 전략적 제휴에 집중하고 있습니다. 전략적 제휴는 진단 툴의 개발 및 적용을 촉진하기 위해 기업, 연구기관, 동물의료기관 간의 협업을 의미합니다. 예를 들어 2025년 11월 미국 수의 진단 기업 Bionote USA는 Vcheck C1 원내 생화학 분석기를 발표했습니다. 이 장비는 저렴한 가격의 컴팩트한 생화학 검사 장비로, 동물의료 현장의 현장 진료(POC) 바이오마커 검사 및 진단 능력의 확대를 목표로 하고 있습니다. Vcheck C1은 소동물 검체에서 최대 24개의 생화학 파라미터를 10-12분 내에 동시에 분석할 수 있으며, 간소화된 워크플로우로 실험실 수준의 정확도를 제공합니다. 개, 고양이, 말, 소 등 34종의 동물종에 대응하며, 각 종별로 검증된 기준 범위를 설정. 종합적인 화학검사, 전해질, 간, 신장, 당뇨 프로파일 등 다양한 검사 항목을 갖추고 있으며, 외부 검사기관에 검체를 보내지 않고도 임상의가 신속하게 진단 및 건강상태를 모니터링할 수 있습니다. 합리적인 가격대와 다양한 동물종에 대한 대응으로 다양한 수의의료 현장에서 신속한 원내 바이오마커 진단에 대한 접근성을 높입니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Veterinary biomarkers are measurable indicators used to diagnose, monitor, and manage diseases in animals. These can include biological molecules such as proteins, genes, or metabolites that reflect a specific physiological or pathological state. Veterinary biomarkers are essential for early disease detection, evaluating treatment efficacy, and understanding disease mechanisms.
The primary types of veterinary biomarkers include biomarkers themselves, kits and reagents, and biomarker readers. Biomarkers are specific biological molecules or substances used to detect, diagnose, and monitor health conditions in animals. These biomarkers, present in blood, urine, or other body fluids, provide important insights into an animal's health status. They are used for various diseases, including inflammatory and infectious diseases, cardiovascular diseases, skeletal muscle diseases, tumors, and more. Applications of these biomarkers span disease diagnostics, preclinical research, and other areas, affecting both companion and production animals.
Tariffs have affected the veterinary biomarkers market by raising costs for imported kits, reagents, and biomarker readers. Segments such as ELISA kits, PCR kits, and optical or fluorescence readers are most impacted, particularly in North America and Europe. While tariffs increase operational costs, they encourage local manufacturing, promote innovation in cost-effective biomarker solutions, and accelerate the adoption of domestic diagnostic technologies.
The veterinary biomarkers market research report is one of a series of new reports from The Business Research Company that provides veterinary biomarkers market statistics, including veterinary biomarkers industry global market size, regional shares, competitors with a veterinary biomarkers market share, detailed veterinary biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biomarkers industry. This veterinary biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary biomarkers market size has grown rapidly in recent years. It will grow from $0.91 billion in 2025 to $1.02 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to reliance on conventional diagnostics, limited biomarker availability, growing prevalence of animal diseases, traditional veterinary research methods, low adoption of preclinical research tools.
The veterinary biomarkers market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2030 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to advancement in biomarker discovery, increasing investment in veterinary diagnostics, rising awareness of animal health monitoring, growth of companion and production animal segments, adoption of automated biomarker readers and digital platforms. Major trends in the forecast period include expansion of diagnostic biomarker development, growth in predictive and prognostic biomarker applications, increasing adoption of elisa, pcr, and rapid test kits, rising use of advanced biomarker readers and analytical devices, growing focus on companion and production animal health.
The rising pet ownership is expected to drive the growth of the veterinary biomarkers market going forward. Pet ownership refers to the state of having one or more animals as companions, where individuals provide care, shelter, and attention to meet their pets' needs and well-being. The increase in pet ownership is attributed to factors such as the desire for companionship, the benefits of pet therapy, and growing awareness of the positive impact pets have on mental and physical health. Veterinary biomarkers support pet ownership by monitoring animal health, enabling early disease detection, and facilitating personalized treatment plans. For example, in June 2025, according to Petfood Industry, a US-based leading resource for pet food and treat manufacturers, 94 million U.S. households owned at least one pet, up from 82 million in 2023, reflecting a significant rise in pet ownership and growing demand for pet care products and services. Therefore, the increase in pet ownership is driving the growth of the veterinary biomarkers market.
Leading players in the veterinary biomarkers market are focusing on strategic partnerships to strengthen their competitive position. Strategic partnerships involve collaborations among companies, research institutions, and veterinary practices to advance the development and application of diagnostic tools. For example, in November 2025, Bionote USA, a US-based veterinary diagnostics company, launched the Vcheck C1 In-Clinic Chemistry Analyzer, an affordable and compact biochemistry testing device designed to expand point-of-care biomarker and diagnostic capabilities in veterinary practices. The Vcheck C1 enables simultaneous analysis of up to 24 biochemical parameters from small animal samples in 10-12 minutes, delivering laboratory-grade accuracy with a simplified workflow. It supports testing across 34 species, including canine, feline, equine, and bovine patients, with validated reference ranges for each species. Featuring broad test panels such as comprehensive chemistry, electrolyte, liver, kidney, and diabetes profiles, the analyzer helps clinicians quickly diagnose and monitor health conditions without sending samples to external laboratories. Its affordable pricing and multi-species support enhance access to rapid, in-clinic biomarker diagnostics across a wide range of veterinary settings.
In November 2025, Zoetis Inc., a US-based provider of animal health medicines, vaccines, diagnostics, and technology solutions, acquired Veterinary Pathology Group (VPG) for an undisclosed amount. Through this acquisition, Zoetis aimed to expand its veterinary diagnostics portfolio, enhancing its ability to provide advanced biomarker and pathology testing solutions to veterinarians in the UK and Ireland while strengthening its global diagnostic footprint. Veterinary Pathology Group is a UK- and Ireland-based provider of comprehensive laboratory diagnostic services supporting biomarker-based testing for disease detection and monitoring in animal health.
Major companies operating in the veterinary biomarkers market are Thermo Fisher Scientific Inc., Zoetis Inc., IDEXX Laboratories Inc., Antech Diagnostics Inc., Neogen Corporation, Heska Corporation, Olink Proteomics, SomaLogic, Life Diagnostics Inc., INDICAL BIOSCIENCE GmbH., Mercodia AB, Bionote USA Inc., Acuvet Biotech, Alertix Veterinary Diagnostics AB., MI:RNA Diagnostics Ltd., Veterinary Biomarkers Inc., Vetmaya Healthcare Private Limited, VolitionRx, BioVet Diagnostics, Randox Laboratories Ltd., Bio-Rad Laboratories Inc., QIAGEN N.V., FidoCure, Scil Animal Care Company GmbH, Shenzhen Mindray Animal Medical Technology Co. Ltd., Esaote SPA, Innovative Diagnostics SAS, Ayoxxa Biosystems
North America was the largest region in the veterinary biomarkers market in 2025. The regions covered in the veterinary biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary biomarkers market consists of sales of biomarker research tools, imaging biomarkers, diagnostic kits, and immunoassays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Biomarkers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veterinary biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary biomarkers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product Type: Biomarkers; Kits And Reagents; Biomarker Readers
2) By Disease Type: Inflammatory And Infectious Diseases; Cardiovascular Diseases; Skeletal Muscle Diseases; Tumor; Other Disease Types
3) By Animal Type: Companion Animals; Production Animals
4) By Application: Disease Diagnostics; Preclinical Research; Other Applications
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Expansion Of Diagnostic Biomarker Development
4.2.2 Growth In Predictive And Prognostic Biomarker Applications
4.2.3 Increasing Adoption Of Elisa, Pcr, And Rapid Test Kits
4.2.4 Rising Use Of Advanced Biomarker Readers And Analytical Devices
4.2.5 Growing Focus On Companion And Production Animal Health
5. Veterinary Biomarkers Market Analysis Of End Use Industries
5.1 Veterinary Hospitals And Clinics
5.2 Diagnostic Laboratories
5.3 Research Institutes
5.4 Preclinical Research Organizations
5.5 Animal Health Service Providers
6. Veterinary Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Veterinary Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Veterinary Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Veterinary Biomarkers Market Size, Comparisons And Growth Rate Analysis
7.3. Global Veterinary Biomarkers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Veterinary Biomarkers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Veterinary Biomarkers Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Veterinary Biomarkers Market Segmentation
9.1. Global Veterinary Biomarkers Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Biomarkers, Kits And Reagents, Biomarker Readers
9.2. Global Veterinary Biomarkers Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inflammatory And Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Other Disease Types
9.3. Global Veterinary Biomarkers Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Companion Animals, Production Animals
9.4. Global Veterinary Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Disease Diagnostics, Preclinical Research, Other Applications
9.5. Global Veterinary Biomarkers Market, Sub-Segmentation Of Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Veterinary Biomarkers Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
ELISA Kits, PCR Kits, Western Blotting Kits, Rapid Test Kits, Reagents For Biomarker Detection
9.7. Global Veterinary Biomarkers Market, Sub-Segmentation Of Biomarker Readers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Veterinary Biomarkers Market
12.1. China Veterinary Biomarkers Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Veterinary Biomarkers Market
13.1. India Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Veterinary Biomarkers Market
14.1. Japan Veterinary Biomarkers Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Veterinary Biomarkers Market
15.1. Australia Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Veterinary Biomarkers Market
16.1. Indonesia Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Veterinary Biomarkers Market
17.1. South Korea Veterinary Biomarkers Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Veterinary Biomarkers Market
19.1. South East Asia Veterinary Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Veterinary Biomarkers Market
20.1. Western Europe Veterinary Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Veterinary Biomarkers Market
21.1. UK Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Veterinary Biomarkers Market
22.1. Germany Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Veterinary Biomarkers Market
23.1. France Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Veterinary Biomarkers Market
24.1. Italy Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Veterinary Biomarkers Market
25.1. Spain Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Veterinary Biomarkers Market
26.1. Eastern Europe Veterinary Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Veterinary Biomarkers Market
27.1. Russia Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Veterinary Biomarkers Market
28.1. North America Veterinary Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Veterinary Biomarkers Market
29.1. USA Veterinary Biomarkers Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Veterinary Biomarkers Market
31.1. South America Veterinary Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Veterinary Biomarkers Market
32.1. Brazil Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Veterinary Biomarkers Market
33.1. Middle East Veterinary Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Veterinary Biomarkers Market
34.1. Africa Veterinary Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Veterinary Biomarkers Market, Segmentation By Product Type, Segmentation By Disease Type, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Veterinary Biomarkers Market Regulatory and Investment Landscape
36. Veterinary Biomarkers Market Competitive Landscape And Company Profiles
36.1. Veterinary Biomarkers Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Veterinary Biomarkers Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Veterinary Biomarkers Market Company Profiles
36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Antech Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Neogen Corporation Overview, Products and Services, Strategy and Financial Analysis
37. Veterinary Biomarkers Market Other Major And Innovative Companies
